ALUMIS INC.
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
ALMS | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 280 EAST GRAND AVENUE, 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.alumis.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Alumis Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for immune-mediated diseases. The company utilizes a precision immunology approach, powered by a proprietary data analytics platform, to drive smarter therapeutic development. Alumis is advancing a late-stage portfolio of next-generation targeted oral therapies designed to replace broad immunosuppression with treatments that address the key drivers of immune dysfunction. Its mission is to optimize patient outcomes and significantly improve the lives of individuals with autoimmune conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ALUMIS INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ALUMIS INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ALUMIS INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
